KRT19 and rheumatoid arthritis: The cytokeratins KRT15 and KRT19 in native form appeared to be targets for autoantibodies in both anti-CCP-positive and anti-CCP-negative RA, and with a 17-fold increase over the background signal defined by donor serum, and native KRT19 stood out as a prominent autoantigen in anti-CCP-positive RA.